Clinical Trials

Phase 1 Active not recruiting

Lymphatic Metastasis, Prostatic Neoplasms

NCT04514484 2026-03-18

Testing the Combination of the Anti-cancer Drugs XL184 (Cabozantinib) and Nivolumab in Patients With Advanced Cancer and HIV

8 enrolled

BreastDermatologicGastrointestinalGenitourinaryGynecologicSarcomaThoracic

Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Carcinoma, Transitional Cell, Carcinoma, Hepatocellular, Lung Neoplasms, Melanoma, Neoplasm Metastasis, Ovarian Neoplasms, Prostatic Neoplasms, Sarcoma, Kaposi, HIV Infections, Carcinoma, Medullary, Small Cell Lung Carcinoma, Triple Negative Breast Neoplasms

NCT04895839 2026-03-18

PC-PEP

2,130 enrolled

Psychological Well-Being, Prostatic Neoplasms

NCT05691465 2026-03-18

Testing the Safety and Effectiveness of Radiation-based Treatment (Lutetium Lu 177 Dotatate) for Metastatic Prostate Cancer That Has Neuroendocrine Cells

30 enrolled

Phase 2 Active not recruiting

Prostatic Neoplasms

NCT05828082 2026-03-18

Testing the Effect of M1774 on Hard-to-Treat Refractory SPOP-mutant Prostate Cancer

20 enrolled

Phase NA Active not recruiting

Prostatic Neoplasms

NCT06408597 2026-03-18

Mannitol Versus Nitroglycerin for Kidney Injury Prevention in Robotic-assisted Radical Prostatectomy or Cystectomy

90 enrolled

Urinary Bladder Neoplasms, Prostatic Neoplasms, Renal Insufficiency, Acute Kidney Injury

NCT06970847 2026-03-18

AMPLIFY

Phase 3 Recruiting

220 enrolled

Phase 1 Not yet recruiting

Prostatic Neoplasms

NCT06982222 2026-03-18

Testing the Safety of the Anti-cancer Drug, Sn-117m-DTPA, for Advanced Cancers That Have Spread to Bones

24 enrolled

BreastGenitourinaryThoracic

Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Prostatic Neoplasms

NCT06995898 2026-03-18

The Vanguard Study: Testing a New Way to Screen for Cancer

BreastGastrointestinalGenitourinaryGynecologicThoracic

24,000 enrolled

Urinary Bladder Neoplasms, Breast Neoplasms, Esophageal Neoplasms, Carcinoma, Hepatocellular, Lung Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms, Stomach Neoplasms, Colorectal Neoplasms

NCT07424547 2026-03-18

Phase I Study of SYS6043 in Patients With Advanced/Metastatic Solid Tumors

Phase 1 Recruiting

386 enrolled

BreastGenitourinaryGynecologicThoracic

Breast Neoplasms, Neoplasms, Ovarian Neoplasms, Prostatic Neoplasms, Small Cell Lung Carcinoma

NCT07480044 2026-03-18

A Phase II Clinical Two-Stage Study of Transcranial Magnetic Stimulation in Preventing Postoperative Delirium in Elderly Patients After Urological Surgery

Phase NA Not yet recruiting

220 enrolled

Emergence Delirium, Carcinoma, Renal Cell, Prostatic Neoplasms

NCT02064673 2026-03-17

Adjuvant Curcumin to Assess Recurrence Free Survival in Patients Who Have Had a Radical Prostatectomy

Phase 3 Recruiting

608 enrolled

Prostatic Neoplasms

NCT02478112 2026-03-17

BioPro-RCMI

Phase NA Terminated

24 enrolled

Phase NA Active not recruiting

Prostatic Neoplasms

NCT03445559 2026-03-17

A Multi-modal, Physician-centered Intervention to Improve Guideline-concordant Prostate Cancer Imaging

58 enrolled 15 charts

Phase 1 Active not recruiting

Prostatic Neoplasms

NCT05245006 2026-03-17

PET Imaging Study of 89Zr-DFO-YS5 in Men With Prostate Cancer

30 enrolled

Prostatic Neoplasms

NCT05888532 2026-03-17

64Cu-GRIP B in Patients With Advanced Malignancies

Phase 1/2 Recruiting

91 enrolled

Kidney Neoplasms, Prostatic Neoplasms, Urethral Neoplasms, Lipodystrophy, Congenital Generalized

NCT06879041 2026-03-17

A Phase I Study of [225Ac]-AZD2284 in Patients With Metastatic Castration-Resistant Prostate Cancer

Phase 1 Recruiting

95 enrolled

BreastCNSDermatologicGastrointestinalGenitourinaryGynecologicThoracic

Prostatic Neoplasms

NCT06926075 2026-03-17

ADVICE

Phase 1/2 Recruiting

80 enrolled

Breast Neoplasms, Glioblastoma, Lung Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms, Skin Neoplasms

NCT07038369 2026-03-17

A Phase 1 Study of ATV-1601 in Patients With Advanced Cancer That Have AKT1 E17K Mutations

Phase 1 Active not recruiting

134 enrolled

BreastGenitourinaryGynecologic

Breast Diseases, Breast Neoplasms, Uterine Cervical Neoplasms, Genital Neoplasms, Female, Neoplasms, Neoplasms by Site, Ovarian Neoplasms, Prostatic Neoplasms, Urogenital Neoplasms, Uterine Neoplasms, Endometrial Neoplasms, Triple Negative Breast Neoplasms

NCT07111507 2026-03-17

A Study of Tarlatamab for People With Prostate Cancer

32 enrolled

Prostatic Neoplasms

NCT07332000 2026-03-17

A Biomarker Study in Men With Localized Prostate Cancer Treated With Aglatimagene Besadenovec

45 enrolled

Adenocarcinoma, Prostatic Neoplasms

NCT07398690 2026-03-17

INSIGHT-PCa

1,432 enrolled

Phase 2 Not yet recruiting

Disease, Prostatic Neoplasms

NCT07476677 2026-03-17

ANDARP

60 enrolled

Phase 3 Active not recruiting

Prostatic Neoplasms

NCT07477626 2026-03-17

RADVAN

374 enrolled

Prostatic Neoplasms

NCT03360721 2026-03-16

Apalutamide, Abiraterone Acetate, and Prednisone in Treating Participants With Metastatic Castration Resistant Prostate Cancer

Phase 2 Terminated

7 enrolled

Prostatic Neoplasms

NCT04037254 2026-03-16

Testing the Addition of a New Anti-Cancer Drug, Niraparib, to the Usual Treatment (Hormone and Radiation Therapy) for Prostate Cancer With a High Chance of Recurring

Phase 1/2 Completed

22 enrolled 13 charts

Phase 4 Active not recruiting

Prostatic Neoplasms

NCT04108208 2026-03-16

A Study of Apalutamide in Chinese Participants With Non Metastatic Castration Resistant Prostate Cancer (NM-CRPC)

75 enrolled 9 charts

Phase 2 Active not recruiting

Prostatic Neoplasms

NCT04190446 2026-03-16

A Study to Evaluate Hypofractionated Proton Therapy or IMRT for Recurrent, Oligometastatic Prostate Cancer

84 enrolled

Phase 2 Active not recruiting

Prostatic Neoplasms

NCT05114746 2026-03-16

Study of 177Lu-PSMA-617 In Metastatic Castrate-Resistant Prostate Cancer in Japan

87 enrolled

Prostatic Neoplasms

NCT05751941 2026-03-16

Study of Sipuleucel-T With or Without Continuing New Hormonal Agents in Metastatic Prostate Cancer

26 enrolled

Prostatic Neoplasms

NCT06056830 2026-03-16

CLARIFY

Phase 3 Recruiting

383 enrolled

Prostatic Neoplasms

NCT06096870 2026-03-16

Enzalutamide and PDS01ADC in PET Positive Recurrent Prostate Cancer (pprPC) Without Testosterone Lowering Therapy

65 enrolled

Prostatic Neoplasms

NCT06651632 2026-03-16

WATER IV PCa

280 enrolled

Prostatic Neoplasms

NCT06780670 2026-03-16

PSMAcTION

Phase 2/3 Recruiting

443 enrolled

Prostatic Neoplasms

NCT07103018 2026-03-16

STRIKE-001

Phase 1 Recruiting

144 enrolled